GALDERMA GROUP AG (GALDY)
PNK · Healthcare · Drug Manufacturers - Specialty & Generic
$43.31
+0.64%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$50.80B
Shares Outstanding
1.17B
Exchange
PNK
Currency
USD
About GALDERMA GROUP AG
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 3.8B | 4.1B | 4.4B | 5.2B |
| Gross Profit | 2.6B | 2.9B | 3.1B | 3.6B |
| Operating Income | 406.0M | 611.0M | 678.0M | 876.0M |
| Net Income | -98.5M | -57.0M | 231.0M | 613.0M |
| Diluted EPS | $-0.08 | $-0.05 | $0.19 | $nan |